Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis ; volume:25 ; number:1 ; day:12 ; month:9 ; year:2023 ; pages:1-12 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (12.9.2023), 1-12, 12.2023

Creator
Cauvet, Anne
Decellas, Arthur
Guignabert, Christophe
Rongvaux-Gaïda, Dominique
Thuillet, Raphaël
Ottaviani, Mina
Tu, Ly
Rieger, François
Avouac, Jérôme
Allanore, Yannick
Contributor
SpringerLink (Online service)

DOI
10.1186/s13075-023-03143-2
URN
urn:nbn:de:101:1-2024020612524366714472
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Cauvet, Anne
  • Decellas, Arthur
  • Guignabert, Christophe
  • Rongvaux-Gaïda, Dominique
  • Thuillet, Raphaël
  • Ottaviani, Mina
  • Tu, Ly
  • Rieger, François
  • Avouac, Jérôme
  • Allanore, Yannick
  • SpringerLink (Online service)

Other Objects (12)

PML-RARA mutations confer varying arsenic trioxide resistance

PML-RARA mutations confer varying arsenic trioxide resistance

Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae

Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia

Metal–organic framework nanoparticles for arsenic trioxide drug delivery

Metal–organic framework nanoparticles for arsenic trioxide drug delivery

Arsenic trioxide as a novel anti-glioma drug: a review

Arsenic trioxide as a novel anti-glioma drug: a review

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9

PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation

PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation

Related objects